Evaluation of the combination of docetaxel/carboplatin in patients with metastatic or recurrent squamous cell carcinoma of the head and neck (SCCHN): a Southwest Oncology Group Phase II study.

Download in:

• JSON
• RDF
• N3/Turtle
• N-Triples

View as

• Triples